Total Debt
$351.7M
Net Debt
-$365.5M
Zenas BioPharma, Inc. currently has $351.7M in total debt. Net debt is -$365.5M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
ZBIO • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.35 | 0.72 | -0.37Net Cash | 0.75 | 47.0% |
| 2025-12-31 | 0.08 | 0.34 | -0.26Net Cash | 0.38 | 20.8% |
| 2025-09-30 | 0.00 | 0.29 | -0.29Net Cash | 0.32 | 0.2% |
| 2025-06-30 | 0.00 | 0.27 | -0.27Net Cash | 0.29 | 0.3% |
| 2025-03-31 | 0.00 | 0.31 | -0.31Net Cash | 0.33 | 0.4% |
| 2024-12-31 | 0.00 | 0.35 | -0.35Net Cash | 0.37 | 0.3% |
| 2024-09-30 | 0.00 | 0.39 | -0.39Net Cash | 0.40 | 0.1% |
| 2024-06-30 | 0.00 | 0.18 | -0.18Net Cash | 0.20 | 0.3% |
| 2024-03-31 | 0.02 | 0.04 | -0.02Net Cash | 0.05 | 44.1% |
| 2023-12-31 | 0.02 | 0.06 | -0.04Net Cash | 0.07 | 31.0% |
| 2023-09-30 | 0.02 | 0.07 | -0.05Net Cash | 0.08 | 25.0% |